|
US4224438A
(en)
|
1970-07-14 |
1980-09-23 |
Boehringer Mannheim Gmbh |
Adenosine-5'-carboxylic acid amides
|
|
US6143749A
(en)
|
1995-06-07 |
2000-11-07 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
|
WO2003039523A2
(en)
|
2001-11-05 |
2003-05-15 |
Exiqon A/S |
OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
|
|
US7034147B2
(en)
|
2001-11-29 |
2006-04-25 |
Irm Llc |
Nucleoside analog libraries
|
|
WO2003070739A1
(en)
|
2002-02-19 |
2003-08-28 |
Cv Therapeutics, Inc. |
Partial and full agonists of a1 adenosine receptors
|
|
US20040043959A1
(en)
|
2002-03-04 |
2004-03-04 |
Bloom Laura A. |
Combination therapies for treating methylthioadenosine phosphorylase deficient cells
|
|
AU2002951247A0
(en)
|
2002-09-06 |
2002-09-19 |
Alchemia Limited |
Compounds that interact with kinases
|
|
EP1645561A1
(en)
|
2003-07-15 |
2006-04-12 |
Mitsui Chemicals, Inc. |
Method of synthesizing cyclic bisdinucleoside
|
|
US20080033172A1
(en)
|
2003-12-19 |
2008-02-07 |
Koronis Pharmaceuticals, Incorporated |
Mutagenic Heterocycles
|
|
EP1844062A2
(en)
|
2005-01-21 |
2007-10-17 |
Methylgene, Inc. |
Inhibitors of dna methyltransferase
|
|
JP2009542608A
(ja)
|
2006-06-29 |
2009-12-03 |
アステックス・セラピューティクス・リミテッド |
医薬組合せ剤
|
|
US20080132525A1
(en)
|
2006-12-04 |
2008-06-05 |
Methylgene Inc. |
Inhibitors of DNA Methyltransferase
|
|
WO2010039548A2
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
|
WO2011075665A2
(en)
|
2009-12-18 |
2011-06-23 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
|
AU2011341441A1
(en)
|
2010-12-03 |
2013-06-20 |
Epizyme, Inc. |
Modulators of histone methyltransferase, and methods of use thereof
|
|
EP2646454B1
(en)
|
2010-12-03 |
2015-07-08 |
Epizyme, Inc. |
7-deazapurine modulators of histone methyltransferase, and methods of use thereof
|
|
WO2012083170A1
(en)
|
2010-12-16 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2694524B1
(en)
|
2011-04-04 |
2016-05-18 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
2'-o-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides
|
|
US20150057243A1
(en)
|
2012-04-02 |
2015-02-26 |
Northern University |
Compositions and Methods for the Inhibition of Methyltransferases
|
|
WO2014035140A2
(en)
|
2012-08-30 |
2014-03-06 |
Kainos Medicine, Inc. |
Compounds and compositions for modulating histone methyltransferase activity
|
|
US20140100184A1
(en)
|
2012-08-31 |
2014-04-10 |
Baylor College Of Medicine |
Selective inhibitors of histone methyltransferase dot1l
|
|
US9365555B2
(en)
|
2012-12-21 |
2016-06-14 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
|
US9604930B2
(en)
|
2012-12-21 |
2017-03-28 |
Epizyme, Inc. |
Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
|
|
US9908887B2
(en)
|
2012-12-21 |
2018-03-06 |
Epizyme, Inc. |
PRMT5 inhibitors and uses thereof
|
|
JP2016505002A
(ja)
|
2012-12-21 |
2016-02-18 |
エピザイム,インコーポレイティド |
ジヒドロイソキノリンまたはテトラヒドロイソキノリンを含有するprmt5阻害剤およびその使用
|
|
JP6510485B2
(ja)
*
|
2013-03-15 |
2019-05-08 |
オハイオ・ステイト・イノベーション・ファウンデーション |
Prmt5インヒビターおよびそれらの使用方法
|
|
JP6510539B2
(ja)
|
2014-01-09 |
2019-05-08 |
ザ ジェイ. デヴィッド グラッドストーン インスティテューツ, ア テスタメンタリー トラスト エスタブリッシュド アンダー ザ ウィル オブ ジェイ. デヴィッド グラッドストーン |
置換ベンゾオキサジン及び関連化合物
|
|
WO2015200680A2
(en)
|
2014-06-25 |
2015-12-30 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
|
BR112016030787B1
(pt)
|
2014-07-01 |
2022-12-20 |
Takeda Pharmaceutical Company Limited |
Entidade química, composição farmacêutica e seu uso
|
|
EA031895B1
(ru)
|
2015-02-24 |
2019-03-29 |
Пфайзер Инк. |
Замещенные нуклеозидные производные, полезные в качестве агентов против рака
|
|
TWI730980B
(zh)
|
2015-08-26 |
2021-06-21 |
比利時商健生藥品公司 |
使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
|
|
CN108884108B
(zh)
|
2016-03-10 |
2021-08-31 |
詹森药业有限公司 |
用于用作prmt5抑制剂的取代核苷类似物
|
|
WO2018065365A1
(en)
|
2016-10-03 |
2018-04-12 |
Janssen Pharmaceutica Nv |
Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors
|
|
BR112019006414A2
(pt)
|
2016-10-03 |
2019-06-25 |
Janssen Pharmaceutica Nv |
análogos de carbanucleosídeos de sistema de anel monocíclico e bicíclico substituídos para uso como inibidores de prmt5
|
|
SG11201907607VA
(en)
|
2017-02-27 |
2019-09-27 |
Janssen Pharmaceutica Nv |
Use of biomarkers in identifying cancer patients that will be responsive to treatment with a prmt5 inhibitor
|
|
MX2020005944A
(es)
|
2017-12-08 |
2020-08-24 |
Janssen Pharmaceutica Nv |
Analogos espirobiciclicos novedosos.
|